HG Meerpohl - St Vincentius Hosp | 人才画像

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 10 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Ten-year Results of Intense Dose-dense chemotherapy show superior survival compared to a conventional schedule in High-risk Primary Breast Cancer: Final results of AGO Phase III iddEPC trial

Möbus V,Jackisch C, Lueck H J,du Bois A, Thomssen C, Kuhn W, Nitz U,Schneeweiss A,Huober J, Harbeck N,von Minckwitz G, Runnebaum I B,

Annals of Oncology（2018）

引用40浏览0WOS引用

Cardiac safety of trastuzumab in combination with epirubicin and cyclophosphamide in women with metastatic breast cancer: results of a phase I trial

M Untch, H Eidtmann,A du Bois,H G Meerpohl, Ch Thomssen, A Ebert, N Harbeck, C Jackisch, V Heilman, G Emons, D Wallwiener, W Wiese,

European journal of cancer (Oxford, England : 1990)no. 7 (2004): 988-97

引用0浏览0WOS引用

Descriptive evaluation of pre-operative selection criteria for operability in recurrent ovarian cancer (desktop-ovar). a study of the ago ovarian cancer study group and the ago organkommission ovar

A. du Bois, D. Fink, W. Schroeder, K. Muenstedt, B. Schmalfeldt, G. Emons, J. Pfisterer, K. Wollschlaeger,H. G. Meerpohl, M. Hahmann, P. Harter

International Journal of Gynecologic Cancerno. Suppl 1 (2004): 17.1-17

引用0浏览0引用

Prospective investigation of the significance of cardiac markers, NT-pro Brain Natriuretic Peptide (NT-proBNP) and Troponin T (TnT), in the Hercules study of epirubicin/cyclophosphamide with or without trastuzumab (Herceptin®)

B Langer,M Muscholl,M Pauschinger, C Thomssen,H Eidtmann, M Untch,H. G Meerpohl,A du Bois,H Weber,H. J Lueck

EJC SUPPLEMENTS（2004）

引用2浏览0引用

A prospective study of NT-pro brain natriuretic peptide and troponin T in the HERCULES study (epirubicin plus cyclophosphamide with or without herceptin) in patients with metastatic breast cancer

B Langer,M Muscholl,M Pauschinger, C Thomssen, H Eidtmann, M Untch,HG Meerpohl,A du Bois,G Schaller,W Kuhn, C Jakisch,R Kreienberg,

BREAST CANCER RESEARCH AND TREATMENTno. SUPnan (2003): S50-S50

引用1浏览0引用

Cardiac safety of epirubicin/cyclophosphamide (EC) alone and in combination with herceptin in women with metastatic breast cancer (MBC)

CH Thomssen, H Eidtmann, M Untch,HG Meerpohl, A du Bos,G Schaller,W Kuhn, CH Jackisch,R Kreienberg, D Wallwiener,W Weise,G Emons,

BREAST CANCER RESEARCH AND TREATMENTno. SUPnan (2002): S111-S111

引用0浏览0引用

Management of a pregnancy complicated by idiopathic thrombozytopenic purpura and diabetes type I

A Mollenkopf,A du Bois,G Hummel,HG Meerpohl

ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIEno. 4.0 (1999): 166-169

引用0浏览0引用

Preliminary results of a phase II study of epirubicin and paclitaxel as first-line treatment in patients with metastatic breast cancer

H J Lück,C Thomssen,A du Bois, B W Lisboa,M Untch, H Kühnle,F Jänicke,H G Meerpohl,C Lindner,G Konecny,D Hecker, K Diergarten

SEMINARS IN ONCOLOGY（1997）

引用28浏览0WOS引用

Phase I study of paclitaxel administered as a 1-hour infusion: toxicity and pharmacokinetics

H Maier-Lenz, B Hauns,B Haering, J Koetting,K Mross,C Unger,T Bauknecht,A du Bois,H G Meerpohl, N Hollaender, K Diergarten

Seminars in oncology（1997）

引用48浏览0WOS引用

Interim Analysis of a Phase II study of epirubicin and paclitaxel as first-line therapy in patients with metastatic breast cancer

H J Luck,C Thomssen, A duBois, B W Lisboa,M Untch, H Kuhnle,G Konecny,F Janicke,H G Meerpohl,C Lindner,D Hecker, K Diergarten

SEMINARS IN ONCOLOGY（1996）

引用47浏览0WOS引用

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn